| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 Oxford University Press
research-article |
Use of angiotensin-converting enzyme inhibitors in elderly patients with heart failure
Department of Geriatric Medicine, Royal Liverpool University Hospital PO Box 147, Prescot Street Liverpool L69 3BX, UK
Address correspondence to: M. Lye. Fax (+44) 151 706 4064. E-mail: m.lye{at}liverpool.ac.uk
OBJECTIVE:: to determine the factors associated with prescription of angiotensin-converting enzyme (ACE) inhibitors in elderly heart failure patients discharged from acute geriatric units.
DESIGN:: retrospective study of case notes.
SETTING:: 12 acute geriatric units in the Mersey region.
SUBJECTS:: 307 patients (median age 82 years; 204 women) with a discharge diagnosis of heart failure.
MAIN OUTCOME MEASURES:: treatment with ACE inhibitors; use of echocardiography; presence of left ventricular systolic dysfunction on echocardiography.
RESULTS:: 176 (57%) patients were discharged from hospital with an ACE inhibitor prescription; a further 19 (6%) patients had been unable to tolerate an ACE inhibitor. One hundred and twenty-one patients (39%) had undergone echocardiography. The proportion of patients in different hospitals who had echocardiography after heart failure ranged from 7 to 67%. Left ventricular systolic dysfunction was reported in 58 patients(48%); 45 of these (78%) were discharged with an ACE inhibitor prescription, seven (12%) had had a previous unsuccessful trial of ACE inhibition and two (3%) had aortic stenosis.
CONCLUSIONS:: the prescribing of ACE inhibitors is satisfactory in elderly heart failure patients attending acute geriatric units in this region who undergo echocardiography. However, the low use of echocardiography in some hospitals is a cause for concern.
Keywords: angiotensin-convrting enzyme inhibitors, audit, echocardiography, heart failure, old age
Received April 9, 1997;
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. D. White, P. E.G. Aylward, Z. Huang, A. J. Dalby, W. D. Weaver, S. Barvik, J. A. Marin-Neto, J. Murin, R. O. Nordlander, W. H. van Gilst, et al. Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Circulation, November 29, 2005; 112(22): 3391 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. Petrie, C. Berry, S. Stewart, and J.J.V. McMurray Failing ageing hearts Eur. Heart J., November 1, 2001; 22(21): 1978 - 1990. [PDF] |
||||

